ReviewInternational journal of molecular sciences2020

The Rationale for Angiotensin Receptor Neprilysin Inhibitors in a Multi-Targeted Therapeutic Approach to COVID-19.

Alessandro Bellis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.